title: [Whooping cough in Spain. Current epidemiology, prevention and control strategies. Recommendations by the Pertussis Working Group].
abstract: A large increase of pertussis incidence has been observed in recent years in countries with high vaccination coverage. Outbreaks of pertussis are increasingly being reported. The age presentation has a bipolar distribution: infants younger 6months that have not initiated or completed a vaccination schedule, and adolescents and adults, due to the lost of natural or vaccine immunity over time. These epidemiological changes justify the need to adopt new vaccination strategies in order to protect young infants and to reduce pertussis incidence in all age groups. Adolescents and adults immunization must be a priority. In the first group, strategy is easy to implement, and with a very low additional cost (to replace dT vaccine by dTap one). Adult vaccination may be more difficult to implement; dT vaccine decennial booster should be replaced by dTap. The immunization of household contacts of newborn infants (cocooning) is the strategy that has a most important impact on infant pertussis. Recently, pregnant women vaccination (after 20weeks of gestation) has been recommended in some countries as the most effective way to protect the newborn.
authors: Sociedad Española de Medicina Preventiva, Salud Pública e Higiene, Spain. mcmarti@telefonica.net
authors: Magda
authors: M
authors: Campins
authors: David
authors: D
authors: Moreno-Pérez
authors: Angel
authors: A
authors: Gil-de Miguel
authors: Fernando
authors: F
authors: González-Romo
authors: Fernando A
authors: FA
authors: Moraga-Llop
authors: Javier
authors: J
authors: Arístegui-Fernández
authors: Anna
authors: A
authors: Goncé-Mellgren
authors: José M
authors: JM
authors: Bayas
authors: Lluís
authors: L
authors: Salleras-Sanmartí
mesh_terms: D000293:Adolescent; D000328:Adult; D001886:Bordetella pertussis / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D022422:Diphtheria-Tetanus Vaccine / Q000008:administration & dosage*; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines / Q000008:administration & dosage*; D005260:Female; D006282:Health Personnel; D006801:Humans; D007115:Immunization Schedule; D007117:Immunization, Secondary; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D010567:Pertussis Vaccine; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D013030:Spain / Q000453:epidemiology; D014611:Vaccination; D014917:Whooping Cough / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control*
chemical_list: D022422:Diphtheria-Tetanus Vaccine; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D010567:Pertussis Vaccine